PreprintCited by 52SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesProtein Structure and Dynamics

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions

Open access

Preprint — published as 10.3389/fviro.2022.830202 · Paper page

Abstract

The genome of the SARS-CoV-2 Omicron variant (B.1.1.529) was released on November 22, 2021, which has caused a flurry of media attention due the large number of mutations it contains. These raw data have spurred questions around vaccine efficacy. Given that neither the structural information nor the experimentally-derived antibody interaction of this variant are available, we have turned to predictive computational methods to model the mutated structure of the spike protein’s receptor binding domain and posit potential changes to vaccine efficacy. In this study, we predict some structural changes in the receptor-binding domain that may reduce antibody interaction without completely evading existing neutralizing antibodies (and therefore current vaccines).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.12.03.471024

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. 10.1038/s41586-020-2008-3 · DOI · Paper page
  2. 10.1038/s41564-020-0770-5 · DOI · Paper page
  3. 10.1016/j.jiph.2021.08.014 · DOI
  4. 10.1101/2021.08.21.21262393 · DOI
  5. 10.1017/ash.2021.222 · DOI
  6. 10.1093/molbev/mst010 · DOI · Paper page
  7. 2021, Fundamental evolution of all orthocoronavirinae including three deadly lineages descendent from chiroptera-hosted coronaviruses: Sars-cov, mers-cov and sars-cov-2, Cladistics, 37, 461, 10.1111/cla.12454 · DOI
  8. 10.1093/nar/gkq291 · DOI
  9. 10.1093/molbev/msz312 · DOI
  10. 10.1126/science.abj8754 · DOI · Paper page
  11. 10.1002/prot.21123 · DOI
  12. 10.1101/2021.08.15.456425 · DOI · Paper page
  13. 10.1016/j.cell.2020.06.025 · DOI · Paper page
  14. 10.1126/science.abd2321 · DOI · Paper page
  15. 10.1038/s41467-020-19231-9 · DOI
  16. 10.1016/j.jmb.2015.09.014 · DOI · Paper page
  17. D. Sharma , P. Rawat , V. Janakiraman , and M. M. Gromiha . Elucidating important structural features for the binding affinity of spike - sars-cov-2 neutralizing antibody complexes. Proteins: Structure, Function, and Bioinformatics, n/a(n/a), 2021. doi: https://doi.org/10.1002/prot.26277. · DOI
  18. 10.1101/2021.12.14.472719 · DOI
  19. 10.1101/2021.12.15.472828 · DOI

Metadata

Authors
Ford, C. T., Machado, D. J., & Janies, D. A.
Affiliations
University of North Carolina at Charlotte (US)
Corresponding author
Ford, Colby T.
Venue
Frontiers in Virology
Publisher
openRxiv
Published
2021-12-06
Volume
2
ISSN
2673-818X (ISSN-L)
OpenAlex
W4225575973
Cited by
52
References
1
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 29 · 2021: 3
FWCI
5.87
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Virology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • DeepMind
  • University of North Carolina at Charlotte
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
Omicron variant, spike protein, receptor binding domain, structure prediction, neutralizing antibodies, antigen-antibody reaction, vaccine efficacy, viral mutations, COVID-19 pandemic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review